Results 241 to 250 of about 754,352 (360)

THE RELATION OF THE DURATION OF GESTATION TO LEGITIMATE BIRTH.Read in the Section of Obstetrics and Diseases of Women, at the Forty- third Annual meeting of the American Medical Association, held at Detroit, June, 1892. [PDF]

, 1892
Taryn Barker
openalex   +1 more source

Shock in Obstetrics [PDF]

BMJ, 1947
openaire   +4 more sources

Predictive biomarkers for regression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2: A prospective multicenter study in Italy

International Journal of Cancer, EarlyView.
What's New? Cervical intraepithelial neoplasia grade 2 (CIN2) lesions can spontaneously regress, especially in women aged under 30. Better predictive biomarkers are needed to improve risk stratification for active surveillance. This prospective multicenter cohort study evaluated HPV genotyping, p16/ki67 expression, and FAM19A4/miR124‐2 methylation ...
Helena Frayle, Silvia Gori, Alessio Pagan, Marika Soldà, Cesare Romagnolo, Egle Insacco, Licia Laurino, Mario Matteucci, Giuseppe Sordi, Enrico Busato, Manuel Zorzi, Tiziano Maggino, Annarosa Del Mistro, CIN2 Study Working Group, Annarosa Del Mistro, Helena Frayle, Silvia Gori, Rossana Trevisan, Alessio Pagan, Justyna Wojciechowska, Enrico Busato, Tiziano Maggino, Marika Soldà, Cesare Romagnolo, Licia Laurino, Pamela Zambenedetti, Egle Insacco, Mario Matteucci, Maria Teresa Gervasi, Giuseppe Sordi, Marco Torrazzina, Manuel Zorzi, Daria Minucci   +32 more
wiley   +1 more source

Management of Cesarean Section Uterine Scar Ectopic Pregnancy Type 2 Using Methotrexate: Insights from a Case Report. [PDF]

Am J Case Rep
Pigg T, Fields S, Brawley A, Roddenberry RP, Woodham PC.   +4 more
europepmc   +1 more source

Can A Catholic Be An Obstetrician-Gynecologist? [PDF]

, 1996
Hilgers, Thomas W.
core   +1 more source

Anti‐Her2 therapy patterns in metastatic breast cancer—Real‐world data suggest undertreatment

International Journal of Cancer, EarlyView.
What's New? Although human epidermal growth factor 2‐positive (HER2+) breast cancer is an aggressive malignancy, significant survival benefits are possible with targeted anti‐HER2 therapies. Whether these therapies are used as recommended, however, is unknown. Here, the authors investigated data from population‐based registries in Norway to assess anti‐
Kathrine F. Vandraas, Sarah Hjorth, Cassia B. Trewin‐Nybråten, Giske Ursin, Edoardo Botteri, Bettina Kulle Andreassen, Kristin V. Reinertsen, Egil S. Blix, Bjørn Naume, Nathalie C. Støer   +9 more
wiley   +1 more source

Internally Filled Fellowship Positions in Obstetrics and Gynecology Before and After 2020. [PDF]

O G Open
McLaughlin HD, Janke MJ, Uppal S, Roberts C, Aaron B, Spencer RJ, Siedel JH, Hong CX.   +7 more
europepmc   +1 more source

American Board of Obstetrics and Gyn ecology

, 1929
FRED C. ZAPFFE
openalex   +1 more source

Long‐term human papillomavirus genotype‐specific risk of cervical high‐grade intraepithelial lesion and cancer—By age group and triage cytology

International Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV) testing has revolutionized cervical cancer screening. Nonetheless, its optimal use for distinguishing between high‐ and low‐risk infections to leverage screening benefits remains to be established. Here, long‐term HPV genotype‐specific risk of precancerous cervical intraepithelial neoplasia grade 2 or higher was ...
Maija Vahteristo, Sirpa Heinävaara, Joakim Dillner, Ilkka Kalliala, Pekka Nieminen, Tytti Sarkeala, Maarit K. Leinonen   +6 more
wiley   +1 more source

Assessing the Reliability of Hysteroscopic Sampling Methods for Diagnosing Atypical Endometrial Hyperplasia. [PDF]

Cancers (Basel)
Giannella L, Piva F, Delli Carpini G, Di Giuseppe J, Giulietti M, Dugo E, Sopracordevole F, Del Fabro A, Clemente N, Gardella B, Bogani G, Brasile O, Martinello R, Caretto M, Ghelardi A, Albanesi G, Stevenazzi G, Venturini P, Papiccio M, Cannì M, Barbero M, Fambrini M, Maggi V, Uccella S, Spinillo A, Raspagliesi F, Greco P, Simoncini T, Petraglia F, Ciavattini A.   +29 more
europepmc   +1 more source